CID 157010066
Avenacin b2
Structural Information
- Molecular Formula
- C54H80O20
- SMILES
- CC1(C2CCC3(C(C2(CCC1OC4C(C(C(CO4)OC5C(C(C(C(O5)CO)O)O)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)CC7C8(C3(CCC9(C8(CC(C(C9)OC(=O)C1=CC=CC=C1)(C)C=O)O)C)C)O7)C)C
- InChI
- InChI=1S/C54H80O20/c1-47(2)30-13-16-51(6)31(19-33-54(74-33)52(51,7)18-17-49(4)20-34(48(3,25-57)24-53(49,54)66)71-43(65)26-11-9-8-10-12-26)50(30,5)15-14-32(47)72-46-42(73-45-41(64)39(62)36(59)28(22-56)69-45)37(60)29(23-67-46)70-44-40(63)38(61)35(58)27(21-55)68-44/h8-12,25,27-42,44-46,55-56,58-64,66H,13-24H2,1-7H3
- InChIKey
- QITTXHVWIJZEEV-UHFFFAOYSA-N
- Compound name
- [21-formyl-23-hydroxy-9-[4-hydroxy-3,5-bis[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy]oxan-2-yl]oxy-6,10,10,14,15,18,21-heptamethyl-2-oxahexacyclo[13.8.0.01,3.05,14.06,11.018,23]tricosan-20-yl] benzoate
- Related CIDs
2D Structure
Profile
Predicted Collision Cross Section
Adduct | m/z | Predicted CCS (Ų) |
---|---|---|
[M+H]+ | 1049.5316 | 315.1 |
[M+Na]+ | 1071.5135 | 310.5 |
[M+NH4]+ | 1066.5581 | 313.2 |
[M+K]+ | 1087.4875 | 318.7 |
[M-H]- | 1047.5170 | 308.6 |
[M+Na-2H]- | 1069.4990 | 329.9 |
[M]+ | 1048.5238 | 312.3 |
[M]- | 1048.5248 | 312.3 |
Literature stripe
No literature data available for this compound.
Patent stripe
No patent data available for this compound.